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Objective: Determine the SenseWear Pro3 Armband (SWA) accuracy for estimating energy expen-
diture (EE)andstepcountduring treadmillwalking incysticfibrosis (CF) compared tohealthyadults.
Hypothesis: SWA estimation of EE would be less accurate for CF, than for healthy subjects, due to
interference with the SWA skin sensors caused by the high salt concentration in the sweat of CF
subjects.
Methods: 17 CF (mean age 26 yr; FEV1 54% predicted) and 17 age-matched control subjects walked
slightly faster than their comfortable pace on a treadmill for 20 min, whilst simultaneously wearing
the SWA and breathing through an open-circuit indirect calorimetry (IC) system. Subjects’ steps
were manually counted.
Results: Combined EE data from all subjects showed no significant difference in EE measured by IC
(6.0 3.4 kcal min1) compared to the SWA estimate (6.3 2.5 kcal min1), however the SWA
significantly overestimated EE at low exercise intensities and underestimated EE at high exercise
intensities.CorrelationsbetweenEEvalues,estimatedby theSWAandmeasuredby IC,weregreater
than 0.85 (p< 0.001) for both the CF and control group. Standard multiple regression showed
that diagnosis of CF independently predicted less than 0.1% of the difference between the IC
measure of EE and the SWA estimate. The SWA recorded slightly but significantly fewer steps
(113 12 stepsmin1) than the manual count (119 9 stepsmin1).
Conclusion: Diagnosis of CF had no significant negative impact on the accuracy of the SWA estimate
of EE. The SWA provided a reasonably accurate estimate of EE and step count during treadmill
walking.
ª 2009 Elsevier Ltd. All rights reserved.y was presented in poster format at the 22nd Annual North American Cystic Fibrosis Conference in
25, 2008. The abstract was published in Pediatric Pulmonology 2008, Supplement 31: A514, p. 386.
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1512 T.J. Dwyer et al.Introduction subjects. We hypothesised that the SWA would be lessExercise is recommended in consensus documents
regarding health care management of people with cystic
fibrosis (CF).1e3 Higher levels of exercise capacity amongst
people with CF are associated with longer survival,4
improved sense of well-being5 and greater employment
capability.6 As well, amongst CF individuals, higher levels of
habitual physical activity are associated with a significantly
slower rate of decline in lung function7 and bone mineral
density8 and a greater exercise capacity in adults9 and
children.10 Therefore, physical activity and its accurate
evaluation are very important for people with CF.
A variety of methods have been used to quantify
habitual physical activity. Subjective measures, such as
interviews, questionnaires and self-report diaries are cheap
and easy to administer but can often be flawed by memory
recall errors and inaccurate perception of activity
behavior.11,12 Stable isotopes, such as doubly labelled
water, are the gold standard measurement of daily energy
expenditure in the free-living environment, however this
technique is costly and does not provide information on
patterns or intensity of physical activity.12 Indirect calo-
rimetry is the gold standard measurement of physical
activity in the laboratory but is too cumbersome for
measurement in the free-living environment.13 Motion
sensors, such as accelerometers and pedometers, are ideal
for the free-living environment and are good at estimating
walking and jogging on flat ground,14 but are poor at esti-
mating upper limb activity15 or walking and running on an
incline.14,16 The addition of heart rate monitors aids esti-
mation of intensity of physical activity17 but can be influ-
enced by fitness level, ambient temperature and emotional
stress.12 The measurement of physical activity in the free-
living environment therefore remains problematic and has
stimulated ongoing development of new technologies.
A recently developed portable physical activity monitor,
the SenseWear Pro3 Armband (SWA, BodyMedia, Pittsburgh,
USA), has been designed to improve the measurement of
physical activity. This activity monitor integrates, through
proprietary non-linear algorithms, subject characteristics
(age, gender, height, weight, handedness and smoking
history), a bi-axial accelerometer, galvanic skin resistance,
heat flux, skin and near body temperature, to estimate
energy expenditure (EE) and step count. Early research
with this device has shown that it can accurately estimate:
resting EE in healthy13,18,19 and obese19 subjects; active EE
in healthy,13,20,21 chronic obstructive pulmonary disease22
and cardiac disease23 subjects; and daily EE in healthy24
and diabetic25 subjects. The only published report on the
accuracy of the SWA’s step count is a pilot study, which
showed the SWA to record 3e4% less steps than the manual
count.26 This pilot study included only eight participants
and did not report the methods employed.
For the estimation of EE, the SWA uses data from phys-
iological sensors placed on the skin. It is unknown if the
high concentration of salt in the sweat of individuals with
CF27 would interfere with the estimation of EE. Hence, the
primary aim of this study was to evaluate the accuracy of
the SWA estimation of EE during treadmill walking in
a group of CF compared to age-matched, healthy controlaccurate in the estimation of EE for the group of CF
subjects than for the group of healthy control subjects. The
secondary aim of this study was to evaluate the accuracy of
the SWA measurement of step count during treadmill




Seventeen adults with CF were recruited from the CF Clinic
at Royal Prince Alfred Hospital, Sydney, Australia and 17
age-matched healthy control participants were recruited
from staff and colleagues of the same hospital (Table 1).
Potential CF subjects were excluded if they had received
a lung transplant, were colonised with Burkholderia cepa-
cia, were not clinically stable or were unable to exercise for
20 min without stopping. Research procedures were
approved by the Ethics Committee of the Sydney South
West Area Health Service and all subjects provided written
informed consent prior to participating in this study.
Measurement of demographic data
Age, height,weight, gender, handedness, smoking history and
lung function were recorded prior to exercising. Spirometry
was performed according to ATS guidelines,28 using the
Vmax229 system (SensorMedics, Yorba Linda, USA) and
reported as a percentage of predicted values.29 Lung function
was tested to assess the clinical status of CF subjects and to
confirm normal respiratory function for the control subjects.
Exercise protocols
Subjects walked on a motorised treadmill (LE200 CE, h/p/
cosmos sports and medical gmbh, Nussdorf-Traunstein,
Germany) for 20 min without slowing down or stopping,
whilst simultaneously wearing the SWA and breathing
through an open-circuit indirect calorimetry system.
Subjects were asked to walk at a speed that was slightly
faster than their comfortable walking pace, which was
intended to elicit moderate intensity exercise. For the first
10 min, the treadmill was set at 0% incline for all subjects
(flat walking) and for the second 10 min, the treadmill was
set at 5% incline for CF subjects and 10% incline for control
subjects (inclinewalking). The incline percentage was based
on pilot data of 15 subjects with CF, which showed that the
average treadmill incline to achieve 60% VO2 peak was 5%. It
was assumed that the control subjects would need to walk at
a higher incline to achieve similar exercise intensity. At the
end of each 10-min period, the subject’s reported dyspnea,
using the modified Borg dyspnea scale,30 and rate of
perceived exertion, using the modified 0e10-point scale,31
were recorded as markers of exercise intensity.
Open-circuit indirect calorimetry
The criterion method for assessing EE during treadmill
walking was breath-by-breath open-circuit indirect
Table 1 Subject characteristics.
CF subjects (nZ 17) Control subjects (nZ 17)
Mean SD Range Mean SD Range
Age (yr) 26 6 18e38 29 7 20e49
Gender 6F : 11M 8F : 9M
BMI (kg m2) 21.4 4.6 15.1e34.6 23.3 3.8 17.1e33.3
FEV1 (predicted %) 54 25 18e90 103 13 82e124
FVC (predicted %) 75 22 39e115 100 18 76e133
Forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) measured as percent of predicted normal lung volume.
29
Activity monitor evaluation in CF and in health 1513calorimetry (IC), using the Vmax229 system. This system
uses Weir’s equation to calculate EE (EEZ 3.94 * VO2þ
1.11 * VCO2),
32 where EE is measured in kilocalories per
minute (kcal min1) and VO2 and VCO2 are measured in litres
perminute (L min1). A pulse oximeter (MasimoCorporation,
Irvine, USA), worn on the subject’s forehead and connected
to the Vmax229 system, provided heart rate data. After
completing the 20-min exercise protocol, the IC and heart
rate data were saved to a computer file, which was randomly
coded, to ensure de-identification at later analysis.
Manual step count
The criterion method for assessing step count during
treadmill walking was manual counting. During both the 10-
min flat and incline walking periods, a research assistant
counted the subject’s steps every third minute.
SenseWear Pro3 Armband
The comparison method for assessing EE and step count
during treadmill walking was the SenseWear Pro3 armband.
Before each exercise trial, the subject’s details (age,
height, weight, gender, handedness and smoking history)
were entered into the SWA software program (InnerView
Research Software v6.1, BodyMedia). As recommended by
the manufacturer, the SWA was worn on the posterior upper
right arm. Once the SWA had acclimatised to the subject
(between 1 and 10 min), the subject was connected to the
IC circuit, and the exercise trial commenced. The SWA
‘‘timestamp’’ button was used to delineate the start of
exercise, the end of the flat walking period and the end of
the incline walking period. After completing the 20-min
exercise protocol, the SWA data was downloaded to the
software program. This program uses proprietary non-linear
algorithms to compute EE from the accelerometry, physi-
ologic sensors and demographic data. This data was then
saved to a computer file, which was randomly coded, to
ensure de-identification at later analysis.
Data analysis
Once all subjects had completed the trial, the exercise
data sheets (including subject details, walking speed,
manual step count, dyspnea and perceived exertion
scores), the IC computer files and the SWA computer files
were analysed by a blinded assessor. From the data sheets,
the assessor calculated the criterion measure of manual
step count for flat and incline walking as the average of the
data collected for 3 min in each 10-min period. From the ICcomputer files, the assessor calculated the criterion
measure of EE and heart rate for flat and incline walking as
the average of the data collected from the IC breath-by-
breath analysis throughout each 10-min period. From the
SWA computer files, the assessor calculated the comparison
estimate of EE and step count for flat and incline walking as
the average of the data collected from the SWA minute-by-
minute analysis throughout each 10-min period. The blin-
ded assessor completed all calculations before unblinding
was performed.
Statistical analysis
Statistical analyses were performed using SPSS software
(version 14.0 for Windows, SPSS Inc., Chicago, USA). Sample
size calculations showed that 17 subjects in each group
would give 80% power to detect a correlation of r> 0.7
between the criterion and comparison values of EE and step
count at a significance level of p< 0.05. Paired t-tests were
calculated for comparison of IC measures of EE and SWA
estimates of EE and for comparison of measures of step
count between manual counting and the SWA. Pearson
correlation coefficients (r) and BlandeAltman33 analyses
were performed to determine agreement and to assess for
any bias between IC measures of EE and the SWA estimates
of EE, and between manual counting and the SWA measures
of step count. Standard multiple regression was conducted
to determine which variables affected accuracy of the EE
estimated by the SWA compared to the EE measured by IC.
Results
All 34 subjects completed the study and there were no
missing data.
Exercise intensity
Subjects walked at an average speed of 5.4 1.0 km h1
(4.7 0.9 km h1 and 6.1 0.7 km h1 for CF and control
subjects respectively). The dyspnea, rate of perceived
exertion and heart rate data during flat and incline walking
for the CF and control group are presented in Table 2.
Energy expenditure
When the EE data from the 34 subjects was combined for
flat and incline walking (for a total of 68 exercise periods),
1514 T.J. Dwyer et al.there was no significant difference in EE measured by IC
compared to that estimated by the SWA (6.0
3.4 kcal min1 and 6.3 2.5 kcal min1 respectively; mean
difference 0.3 kcal min1, 95%CI 0.2 to 0.8). However,
when exercise periods were divided into flat and incline
walking (Table 3), the SWA significantly overestimated EE
compared to IC during flat walking for both the CF and
control group. During incline walking, the SWA non-signifi-
cantly overestimated EE compared to IC for the CF group
and significantly underestimated EE compared to IC for the
control group.
There were significant strong correlations between EE
values measured by IC and estimated by the SWA during flat
walking for both the CF and control group (rZ 0.89,
p< 0.001; rZ 0.85, p< 0.001 respectively) and during
incline walking for both the CF and control group (rZ 0.87,
p< 0.001; rZ 0.92, p< 0.001 respectively). The Blande
Altman plot for EE during flat and incline walking for all
subjects is shown in Fig. 1. Ninety percent (61 of 68 exer-
cise periods) were within two standard deviations of the
difference between the IC measure of EE and the SWA
estimate of EE (4.0 kcal min1). The analysis also high-
lighted that the SWA tended to underestimate EE at high
exercise intensities (greater than 8 kcal min1).
Although the mean difference in EE, between flat and
incline walking, detected by the SWA was less than that
measured by IC, the SWA did significantly detect the
change in exercise intensity from flat to incline walking in
both the CF and control group. The mean difference in EE
between flat and incline walking for the CF group was
1.6 kcal min1 (95%CI 1.1 to 2.0) for IC measurement and
0.7 kcal min1 (95%CI 0.3 to 1.1) for SWA estimation. The
mean difference in EE between flat and incline walking for
the control group was 5.1 kcal min1 (95%CI 4.1 to 6.0)
for IC measurement and 1.2 kcal min1 (95%CI 0.9 to 1.6)
for SWA estimation.
Standard multiple regression was performed with all 68
exercise periods combined to determine which variables
affected the SWA estimation of EE. Of particular interest
was to evaluate if CF subjects, compared to control
subjects, had less accurate SWA estimates of EE compared
to the IC measures of EE. The dependent variable was the
absolute difference in EE between the IC measurement and
the SWA estimate (i.e. the difference between the criterion
and comparison method for EE values). The independent
variables entered into the regression analysis were: group
(CF or control); gender; body mass index (BMI); andTable 2 Exercise intensity during treadmill walking.
Flat walking
Dyspnea RPE HR (bpm)
CF (nZ 17) 1.2 1.0 1.1 1.0 111 10
Control (nZ 17) 0.7 0.9 0.7 0.6 108 9
CF vs Control 0.5 (0.1 to 1.2) 0.4 (0.2 to 1.0) 3 (4 to 9)
Group values for mean standard deviation of Borg dyspnea,30 rate
(bpm) for CF and control subjects during flat and incline walking,
Comparisons between the CF and control group are shown as group m
*p< 0.001.
ypZ 0.01.exercise intensity (VO2 in Lmin
1). The independent vari-
ables that significantly reduced the accuracy of the SWA
estimate were having a higher BMI and exercising at
a higher intensity. Both of these variables independently
predicted 8% (p< 0.001) of the difference between the IC
measure of EE and the SWA estimate of EE. Diagnosis of CF
independently predicted less than 0.1% of the difference
between the IC measure of EE and the SWA estimate of EE.
Step count
There was no change in walking speed between flat and
incline walking, so the 68 exercise periods were combined
for analysis of step count between manual counting and
SWA measurement. The SWA recorded slightly but signifi-
cantly fewer steps than those recorded by manual counting
(113 12 steps min1 and 119 9 steps min1 respectively;
mean difference 7 steps min1, 95%CI 5 to 9). The SWA step
count over-recorded the manual step count in only one
exercise period and this was by 3 steps min1. There was
a significant strong correlation between step count
measured by manual counting and the SWA (rZ 0.66,
p< 0.001). A BlandeAltman analysis (Fig. 2), determined
that 94% (64 of the 68 exercise periods) were within two
standard deviations of the difference between the two
values of step count (18 steps min1), and the greatest
under-scoring of step count occurred at slower cadences
(less than 116 steps min1).
Discussion
The primary purpose of this study was to evaluate the
accuracy of the SWA estimation of EE during treadmill
walking in a group of adults with CF compared to a group of
age-matched, healthy control subjects. The validity of the
SWA estimate of EE was assessed by comparing its results
with the simultaneous measurement of EE by IC. To our
knowledge, this is the first study investigating the accuracy
of the SWA in CF patients.
Contrary to our hypothesis, diagnosis of CF had no
significant negative impact on the accuracy of the SWA
estimation of EE. Calculation by multiple regression showed
that diagnosis of CF independently predicted less than 0.1%
of the difference in EE estimated by the SWA compared to
IC measurement. Although we did not formally measure the
amount of sweat or salt content in the sweat producedIncline walking
Dyspnea RPE HR (bpm)
2.9 1.6 2.4 1.7 128 11
3.7 1.9 4.3 2.3 149 15
0.8 (2.0 to 0.5) 1.9y (3.3 to 0.4) 20* (29 to 11)
of perceived exertion (RPE)31 and heart rate (HR) in beats min1
as reported by the subject and measured by pulse oximetry.
ean differences and (95%CI).
Table 3 Energy expenditure during treadmill walking.
Flat walking EE (kcal min1) Incline walking EE (kcal min1) Incline vs flat
IC SWA SWA vs IC IC SWA SWA vs IC SWA
CF (nZ 17) 3.6 1.7 5.1 2.4 1.5* (0.9 to 2.1) 5.1 2.5 5.8 2.7 0.6 (0.1 to 1.3) 0.7y (0.3 to 1.1)
Control (nZ 17) 5.2 1.6 6.7 2.0 1.5* (0.9 to 2.0) 10.3 3.3 7.9 2.1 2.4* (3.2 to 1.6) 1.2* (0.9 to 1.6)
Group values for mean standard deviation of energy expenditure (EE) in kcal min1, as measured by indirect calorimetry (IC) and
estimated by the SenseWear Pro3 Armband (SWA), for CF and control subjects during flat and incline walking. Comparisons between the
EE values, measured by IC and estimated by the SWA, are shown as group mean differences and (95%CI). Comparisons between the EE
values estimated by the SWA during incline walking and flat walking are shown as group mean differences and (95%CI).
*p< 0.001.
ypZ 0.002.
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were documented to have sweated. It can therefore be
assumed that the high concentration of salt in the sweat of
CF individuals does not interfere with the physiological skin
sensors and data collection for the estimation of EE with
the SWA.
While diagnosis of CF did not impact the ability of the
SWA to accurately estimate EE, the multiple regression
analysis in this study indicated that exercise intensity
significantly affected the accuracy of the EE estimate. Our
results showed that the SWA underestimated EE at higher
exercise intensities. Previous investigations of the SWA
estimation of EE during walking in young, healthy
subjects,13,20 patients with chronic obstructive pulmonary
disease22 and cardiac disease23 all reported this sameFigure 1 BlandeAltman plot between the IC measurement
and SWA estimate of EE during flat and incline treadmill
walking for all subjects (nZ 34, two exercise periods). The
solid horizontal line represents the mean difference between
the IC measure of EE and the SWA estimate of EE
(þ0.3 kcal min1). The broken horizontal lines represent the
limits of agreement corresponding to 2 SD of the difference
between the IC measure of EE and the SWA estimate of EE
(4.0 kcal min1).observation for the SWA to increasingly underestimate EE
with increasing exercise intensity.
Further analysis combining flat and incline walking for
all CF and control subjects showed that the SWA provided
an accurate estimate of EE, as evidenced by a mean
difference of only 0.3 kcal min1 compared to measure-
ment of EE by IC. In addition, individual results, comparing
the SWA estimate of EE to IC measurement of EE by
correlation and BlandeAltman analyses, showed strong
agreement between the two measurement techniques.
Correlations between the two techniques were greater
than 0.85 for both the CF and control group at each level of
incline. These results are markedly higher than for previ-
ously published work, which used older SWA models and
InnerView software, when comparing SWA estimates of EE
to IC measurement during treadmill walking at similar
speeds and incline, with correlations ranging from 0.47 to
0.76.13,20
Another important finding from this study was that the
SWA, using the latest commercially available InnerView
software (v6.1), was able to detect the change in exercise
intensity, as measured by EE, elicited by a change inFigure 2 BlandeAltman plot between the manual count and
SWA measurement of step count during treadmill walking for all
subjects (nZ 34, two exercise periods). The solid horizontal line
represents the mean difference between the manual count and
theSWAmeasurementof stepcount (7 stepsmin1).Thebroken
horizontal lines represent the limits of agreement corresponding
to2 SDof thedifferencebetween themanual count and theSWA
measurement of step count (18 stepsmin1).
1516 T.J. Dwyer et al.treadmill incline. This finding was significant for both the
CF group, with a change from 0% to 5% incline, and the
control group, with a change from 0% to 10% incline. Earlier
research, using older versions of the software (v1.0 and
v3.2), showed only a detection in the change in exercise
intensity from a change in speed,13,21 but not from a change
in incline.13,20 Our results would suggest that the SWA, with
the newer software, may perform better when measuring
physical activity in the free-living environment than stan-
dard motion sensors, which often failed to detect changes
in incline.14,16
The secondary purpose of this study was to evaluate the
accuracy of the SWA measurement of step count during
treadmill walking. The validity of the SWA measure of step
count was assessed by comparing the results with a simul-
taneous manual count. To our knowledge, this is the first
detailed study to evaluate the accuracy of the SWA
measure of step count.
The SWA provided a reasonably accurate measure of step
count compared tomanual counting during treadmill walking.
The average SWA step count was 5% less than the average
manual count. This result is similar to a pilot study, which
showed the SWA step count to be 3e4% less than the manual
count.26 Our result is comparable to other studies investi-
gatingmotion sensors and pedometers, which areworn on the
trunk or lower limb and specifically designed to measure step
count.34e36 Monitors of step count are considered ‘‘extremely
accurate’’ if within 3% of the manual count and ‘‘accept-
able’’ if within 10% of the manual count.35
In summary, the diagnosis of CF did not affect the
accuracy of the SWA estimation of EE. The SWA provided
a reasonably accurate estimate of physical activity, in
terms of EE and step count, during treadmill walking for
both CF and young, healthy control subjects. Although the
SWA significantly underestimated EE at higher exercise
intensities, the algorithms in the latest commercially
available software provided better agreement with
measurement of EE by IC than previously reported in
studies using older software13,20 and were able to detect
changes in exercise intensity with changing treadmill
incline. The SWA would therefore be a useful tool when
measuring physical activity in CF when IC is too cumber-
some or difficult.Acknowledgements
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